Depo-Provera and Meningioma Brain Tumors Lawsuit

The lawyers at Johnson//Becker, PLLC, are investigating injuries associated with Pfizer’s Depo-Provera. Depo-Provera was approved by the Food & Drug Administration (FDA) in 1992 as an injectable form of birth control. Rather than daily pills, women who use Depo-Provera receive a shot every three months. It is estimated that over 74 million women globally rely on this medication.

Recent findings have indicated a potential link between Depo-Provera and meningioma brain tumors. Meningiomas, though generally benign, can grow and impact brain function, causing symptoms like seizures, vision problems, and cognitive impairment, among others. Meningioma is treated with surgical removal and may include radiation and chemotherapy.

A French study from 2024 published in the British Medical Journal found a significantly higher risk of meningiomas for users of progestin drugs. Specifically, women who used medroxyprogesterone (the active ingredient in Depo-Provera) were found to be at least five times more likely to develop these tumors. The same study did not show an increased risk of meningiomas in women using oral contraceptives.

Questions About a Depo-Provera Lawsuit? Contact a Johnson//Becker Lawyer for a Free Case Review

If you developed a meningioma brain tumor and you took Depo-Provera, even if it was many years later, you may want to speak with the lawyers at Johnson//Becker. We are currently accepting new cases for those affected by Depo-Provera nationwide, and you may be entitled to financial compensation.

We offer a Free Case Evaluation. Please use the form below to contact us or call (800) 279-6386. We would be honored to speak with you and respond promptly to every inquiry.

Free Case Evaluation

Verified 100% Secure Site To contact us for a free review of your potential case, please fill out the form below or call us toll free 24 hrs/day by dialing: (800) 279-6386.